Arkolith/Insider Trading/RIGL/Form 4

Schorno Dean L

EVP & Chief Financial OfficerRIGEL PHARMACEUTICALS INC (RIGL) · full profile →Form 4 · filed Jun 3, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 1, 2026Option exercise(M)1K$18.70$22K78K
Jun 1, 2026Option exercise(M)2K$12.70$28K80K
Jun 1, 2026Tax withholding(F)928$29.86$28K79K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 1, 2026Option exercise(M)1K—$010K
Jun 1, 2026Option exercise(M)2K—$014K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-26-002811) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML